---
title: "HUAPONT LIFE SCIENCES: Elected Zhang Songshan as Chairman"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/240152655.md"
description: "On May 14th, HUAPONT LIFE SCIENCES announced that the board of directors elected Zhang Songshan as the chairman of the ninth board of directors, elected Wang Rong as the vice chairman, and appointed Zhang Haian as the company's general manager"
datetime: "2025-05-14T11:28:21.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/240152655.md)
  - [en](https://longbridge.com/en/news/240152655.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/240152655.md)
---

# HUAPONT LIFE SCIENCES: Elected Zhang Songshan as Chairman

On May 14th, HUAPONT LIFE SCIENCES announced that the board of directors elected Zhang Songshan as the chairman of the ninth board of directors, elected Wang Rong as the vice chairman, and appointed Zhang Haian as the company's general manager

### Related Stocks

- [002004.CN](https://longbridge.com/en/quote/002004.CN.md)

## Related News & Research

- [Fresenius says FDA, EMA accept Vedolizumab biosimilar PB016 filings for review](https://longbridge.com/en/news/294463337.md)
- [11:00 ETUnderstanding Lymph System Supplements: Nation Health MD Highlights Natural Support for Everyday Lymphatic Wellness](https://longbridge.com/en/news/294585873.md)
- [11:01 ETDRYOUT® Introduces a New Category of Gear Protection with UAG Collaboration](https://longbridge.com/en/news/294385442.md)
- [12:00 ETFirst Federal Bank Launches FFB Connect, Bringing Personalized Banking to Customers Wherever They Are](https://longbridge.com/en/news/294535763.md)
- [07:00 ETRactigen Therapeutics Announces U.S. FDA IND Clearance for First-in-Class saRNA Candidate RAG-1C to Treat Proliferative Vitreoretinopathy](https://longbridge.com/en/news/294502084.md)